Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Nurse or pharmacist led GDMT management programs have been shown to effectively increase GDMT rates. The Veterans Healthcare Administration (VHA) has a pharmacist-based HF remote management program that uses an online, real-time, patient dashboard to optimize HF therapy. However, only a minority of VHA patients with recent-onset HF received HF care from pharmacists, with many of the encounters being limited to monitoring and education. Expanding the pharmacist program is a goal, but how to successfully implement this is unclear.
The PHARM-HF-2 Project is a multi-site pragmatic randomized quality improvement project that evaluates two different interventions. First, the project evaluates if education and feedback messages increase the frequency of pharmacist HF medication management compared with education alone. Second, the project evaluates if primary care nudges to refer patients with heart failure to pharmacy care increase the frequency of pharmacist HF medication management compared with usual care.
PHARM-HF-2 is a cluster randomized project at the level of the clinical site in a stepped wedge design. A total of 22 VHA sites will be randomized to different time points at which they begin receiving the intervention. In the initial phase, all sites will receive education only. At intervals of 2 months, 4 sites will transition from education only to audit and feedback with education in a randomized order. By the end of the project, all sites will be receiving the monthly audit and feedback intervention.
The second implementation strategy is nested within the primary strategy among sites randomized to education and feedback. Primary care referral nudges will studied with a two-arm parallel design with randomization at the level of the primary care team (PACT team) with 1:1 allocation stratified by site. This nested evaluation will start four months into the study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Education Only | Active Comparator | Pharmacists practicing at sites randomized to Education Only |
|
| Education and Feedback (E+F) without Primary Care Referral Nudges | Experimental | Pharmacists practicing at sites randomized to education and feedback but not primary care referral nudges in the nested implementation strategy. |
|
| Education and Feedback (E+F) with Primary Care Referral Nudges | Experimental | Pharmacists practicing at sites randomized to education and feedback and the primary care referral nudges in the nested implementation strategy. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Education Only | Other | Pharmacists will be informed regarding the educational material on a VHA Sharepoint site. The educational information will include suggested titration protocols, education about heart failure medications, a frequently asked questions document, guideline documents, patient educational material, and recordings of Teams webinars on heart failure management. The pharmacists will be invited to a regular webinar regarding heart failure medication management. |
| Measure | Description | Time Frame |
|---|---|---|
| Monthly heart failure medication adjustment encounters | Number of encounters in which pharmacist adjusted heart failure medications | Up to 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Pharmacist Heart Failure Encounters | Number of encounters in which pharmacist documented heart failure care | Up to 12 months |
| Guideline medical therapy score | Composite score of heart failure medical therapy among patients with heart failure for patients within each pharmacists panel (Score range 0-18 with higher scores indicating higher amounts of medical therapy) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Palo Alto Veterans Affairs Healthcare System | Palo Alto | California | 94304 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Jul 10, 2025 | Sep 1, 2025 | Prot_000.pdf |
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D004522 | Educational Status |
| ID | Term |
|---|---|
| D012959 | Socioeconomic Factors |
| D011154 | Population Characteristics |
Not provided
Not provided
This is a multisite randomized quality improvement project. The project evaluates two separate interventions to increase pharmacist HF medication adjustment. In a stepped wedge randomized design, the study will compare education and feedback versus education alone. The education and feedback intervention will be randomized at the level of the clinical site. A total of 22 VHA sites will be randomized to different time points at which they begin receiving the intervention. In the initial phase, all sites will receive education only. At intervals of 2 months, 4 sites will transition from education only to education and feedback in a randomized order. By the end of the project, all sites will be receiving the monthly education and feedback intervention.
The second component of the project will be a parallel randomized project comparing primary care pharmacist referral nudges with usual care. This second project will be nested within sites randomized to education an
Not provided
Not provided
Not provided
Not provided
|
| Education and Feedback (E+F) | Other | Primary care pharmacists with a heart failure action within the last year will receive a monthly Teams message. The monthly Teams message will contain information including their heart failure medication actions over the prior 3 month period. This data will be obtained from VHA pharmacy data. The message will also include reminders regarding the monthly educational sessions and access to the educational sharepoint. They will also receive a Teams calendar hold for the monthly educational meeting. |
|
| Primary Care Referral Nudges | Other | Primary care clinicians will receive a weekly email that lists potential patients with HF with reduced ejection fraction with upcoming clinic visits that are not on optimal medication therapy. The message will suggest referral to PACT pharmacists for medication optimization. |
|
| At 12 months follow-up |
| Beta-blocker therapy | Percentage of patients with heart failure with reduced ejection fraction in each pharmacist panel that are treated with beta-blocker therapy | At 12 months follow-up |
| Renin-angiotensin system inhibitor (RASI) therapy | Percentage of patients with heart failure with reduced ejection fraction in each pharmacist panel that are treated with RASI therapy | At 12 months follow-up |
| Angiotensin receptor neprilysin inhibitor (ARNI) therapy | Percentage of patients with heart failure with reduced ejection fraction in each pharmacist panel that are treated with ARNI therapy | At 12 months follow-up |
| Mineralocorticoid receptor antagonist (MRA) therapy | Percentage of patients with heart failure in each pharmacist panel that are treated with MRA therapy | At 12 months follow-up |
| Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) therapy | Percentage of patients with heart failure in each pharmacist panel that are treated with SGLT2i therapy | At 12 months follow-up |